Skip to main content
Fig. 2 | Radiation Oncology

Fig. 2

From: Nadir PSA is a strong predictor of treatment outcome in intermediate and high risk localized prostate cancer patients treated by definitive external beam radiotherapy and androgen deprivation

Fig. 2

a Kaplan Meier survival curve of biochemical free survival rates for T1-T2 versus T3-T4 stage. b Kaplan Meier survival curve of biochemical free survival as a function of nadir PSA (nPSA) with the cutoff of 0.06 ng/ml. c Kaplan Meier survival curve of biochemical free survival rates for patients with Gleason’s score (GS) < 8 and those with GS 8–10

Back to article page